Journal of The Academy of Clinical Microbiologists

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  26 (2024)
Volume  23 (2021)
Volume  22 (2020)
Volume  21 (2019)
Volume  20 (2018)
Volume  19 (2017)
Volume  18 (2016)
Volume  17 (2015)
Volume  16 (2014)
Volume  15 (2013)
Related articles

VOLUME 20 , ISSUE 1 ( January-June, 2018 ) > List of Articles

Original Article

The emergence of Mupirocin resistance among the clinical isolates of Staphylococci in a rural tertiary health-care centre of South India

Vijaya Shivanna, R Nanda Kumar, D Venkatesha

Keywords : High-level Mupirocin resistance, inducible Clindamycin resistance, low-level Mupirocin resistance, Methicillin resistance, Staphylococci

Citation Information : Shivanna V, Kumar RN, Venkatesha D. The emergence of Mupirocin resistance among the clinical isolates of Staphylococci in a rural tertiary health-care centre of South India. 2018; 20 (1):14-18.

DOI: 10.4103/jacm.jacm_18_17

License: CC BY-NC 4.0

Published Online: 17-08-2024

Copyright Statement:  Copyright © 2018; Wolters Kluwer India Pvt. Ltd.


Abstract

INTRODUCTION: Mupirocin is mainly used for decolonisation of Methicillin-resistant Staphylococcus aureus among patients and health-care workers. However resistance originates from coagulase negative staphylococci (CoNS) and spreads to S. aureus by horizontal gene transfer. Hence, the present study was done to determine the overall prevalence of high- and low-level Mupirocin resistance among S. aureus and CoNS and correlate with the occurrence of Methicillin and inducible Clindamycin resistance. MATERIALS AND METHODS: A total of 100 consecutive, non-repetitive, clinical isolates of Staphylococci were obtained from various samples in a rural tertiary care hospital of Karnataka between August and September 2016. Antibiotic susceptibility testing was done according to the Clinical and Laboratory Standards Institute (M100-S25, 2015) guidelines. Low- and high-level Mupirocin resistance was screened using 5 μg and 200 μg discs, respectively. RESULTS: Of 100 staphylococcal isolates, high-level Mupirocin resistance (MupRH) was detected in 13 isolates and low-level Mupirocin resistance (MupRL) was found in 4 isolates. Of 13 HLMR isolates, majority were CoNS (12 out of 13, 92.31%). Even in LLMR isolates, 75% (3 out of 4) were CoNS. All the HLMR and LLMR isolates were Methicillin resistant (P < 0.05). CONCLUSION: High prevalence of Mupirocin resistance was found in the present study. Hence, screening for Mupirocin resistance should be routinely done and the drug must be used judiciously.

PDF Share
  1. Patel JB, Gorwitz RJ, Jernigan JA. Mupirocin resistance. Clin Infect Dis 2009;49:935-41.
  2. Hetem DJ, Bonten MJ. Clinical relevance of mupirocin resistance in Staphylococcus aureus. J Hosp Infect 2013;85:249-56.
  3. Hurdle JG, O'Neill AJ, Ingham E, Fishwick C, Chopra I. Analysis of mupirocin resistance and fitness in Staphylococcus aureus by molecular genetic and structural modeling techniques. Antimicrob Agents Chemother 2004;48:4366-76.
  4. Collee JG, Marr W. Culture of bacteria. In: Collee JG, Fraser AG, Marmion BP, Simmons A, editors. Mackie and McCartney Practical Medical Microbiology. 14th ed. New York: Churchill Livingstone; 2006. p. 113-29.
  5. Clinical and Laboratory Standards Institute. M100-S25. Performance Standards for Antimicrobial Susceptibility Testing: 24th Informational Supplement. Wayne, PA: CLSI; 2015.
  6. Clinical and Laboratory Standards Institute. M100-S25. Screening Test for Detection of High-Level Mupirocin Resistance in Staphylococcus aureus: 24th Informational Supplement. Wayne, PA: CLSI; 2015.
  7. Caffrey AR, Quilliam BJ, LaPlante KL. Risk factors associated with mupirocin resistance in meticillin-resistant Staphylococcus aureus. J Hosp Infect 2010;76:206-10.
  8. Oommen SK, Appalaraju B, Jinsha K. Mupirocin resistance in clinical isolates of Staphylococci in a tertiary care centre in South India. Indian J Med Microbiol 2010;28:372-5.
  9. Rudresh MS, Ravi GS, Motagi A, Alex AM, Sandhya P, Navaneeth BV, et al. Prevalence of mupirocin resistance among staphylococci, its clinical significance and relationship to clinical use. J Lab Physicians 2015;7:103-7.
  10. Abimanyu N, Murugesan S, Krishnan P. Emergence of methicillin-resistant Staphylococcus aureus ST239 with High-level mupirocin and inducible clindamycin resistance in tertiary care center in Chennai, South India. J Clin. Microbiol 2012;50:3412-3.
  11. Gadepalli R, Dhawan B, Mohanty S, Kapil A, Das BK, Chaudhry R, et al. Mupirocin resistance in Staphylococcus aureus in an Indian hospital. Diagn Microbiol Infect Dis 2007;58:125-7.
  12. Jayakumar S, Meerabai M, Banu SA, Mathew R, Kalyani M, Lal LY, et al. Prevalence of high and low level mupirocin resistance among staphylococcal isolates from skin infection in a tertiary care hospital. J Clin Diagn Res 2013;7:238-42.
  13. Chaturvedi P, Singh AK, Singh AK, Shukla S, Agarwal L. Prevalence of mupirocin resistant Staphylococcus aureus isolates among patients admitted to a tertiary care hospital. N Am J Med Sci 2014;6:403-7.
  14. Bathoorn E, Hetem DJ, Alphenaar J, Kusters JG, Bonten MJ. Emergence of high-level mupirocin resistance in coagulase-negative staphylococci associated with increased short-term mupirocin use. J Clin Microbiol 2012;50:2947-50.
  15. Desroches M, Potier J, Laurent F, Bourrel AS, Doucet-Populaire F, Decousser JW, et al. Prevalence of mupirocin resistance among invasive coagulase-negative staphylococci and methicillin-resistant Staphylococcus aureus (MRSA) in France: Emergence of a mupirocin-resistant MRSA clone harbouring mupA. J Antimicrob Chemother 2013;68:1714-7.
  16. Cadilla A, David MZ, Daum RS, Boyle-Vavra S. Association of high-level mupirocin resistance and multidrug-resistant methicillin-resistant Staphylococcus aureus at an academic center in the Midwestern United States. J Clin Microbiol 2011;49:95-100.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.